Tumor necrosis factor-like weak inducer of apoptosis increases CC chemokine ligand 20 production in interleukin 1β-stimulated human gingival fibroblasts

Human Immunology

Volumn 73, Issue 5, 2012, Pages 470-473

  Hosokawa, Yoshitaka ^a   Hosokawa, Ikuko ^a   Shindo, Satoru ^a   Ozaki, Kazumi ^a   Nakae, Hideaki ^a   Matsuo, Takashi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

CCL20; Human gingival fibroblasts; IL 1 ; TWEAK

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 3 (4 TERT BUTYLPHENYLSULFONYL) 2 PROPENENITRILE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; APOPTOSIS INDUCING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; TUMOR NECROSIS FACTOR LIKE WEAK INDUCER OF APOPTOSIS; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FIBROBLAST; GINGIVA; GINGIVAL BIOPSY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRACELLULAR SIGNALING; PERIODONTAL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH17 CELL; WESTERN BLOTTING;

CELL MOVEMENT; CHEMOKINE CCL20; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; GENE EXPRESSION; GINGIVA; HUMANS; INTERLEUKIN-1BETA; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PERIODONTAL DISEASES; PHOSPHORYLATION; PRIMARY CELL CULTURE; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TH17 CELLS; TUMOR NECROSIS FACTORS;

EID: 84860258005     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.02.021     Document Type: Article

References (18)

1. Burkly L.C., Michaelson J.S., Hahm K., Jakubowski A., Zheng T.S. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease. Cytokines 2007, 40:1-16.
2. Chicheportiche Y., Chicheportiche R., Sizing I., Thompson J., Benjamin C.B., Ambrose C., et al. Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies. Arthritis Res 2002, 4:126-133.
3. Kim S.H., Kang Y.J., Kim W.J., Woo D.K., Lee Y., Kim D.I., et al. TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages. Circ J 2004, 68:396-399.
4. Kamijo S., Nakajima A., Kamata K., Kurosawa H., Yagita H., Okumura K. Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA. Rheumatol Oxf Engl 2008, 47:442-450.
5. Lynch C.N., Wang Y.C., Lund J.K., Chen Y.W., Leal J.A., Wiley S.R. TWEAK induces angiogenesis and proliferation of endothelial cells. J Biol Chem 1999, 274:8455-8459.
6. Donohue P.J., Richards C.M., Brown S.A., Hanscom H.N., Buschman J., Thangada S., et al. TWEAK is an endothelial cell growth and chemotactic factor that also potentiates FGF-2 and VEGF-A mitogenic activity. Arterioscler Thromb Vasc Biol 2003, 23:594-600.
7. Hosokawa Y., Hosokawa I., Ozaki K., Nakae H., Matsuo T. Proinflammatory effects of tumour necrosis factor-like weak inducer of apoptosis (TWEAK) on human gingival fibroblasts. Clin Exp Immunol 2006, 146:540-549.
8. Doodes P.D., Cao Y., Hamel K.M., Wang Y., Farkas B., Iwakura Y., et al. Development of proteoglycan-induced arthritis is independent of IL-17. J Immunol 2008, 181:329-337.
9. Kramer J.M., Gaffen S.L. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J Periodontol 2007, 78:1083-1093.
10. Hirota K., Yoshitomi H., Hashimoto M., Maeda S., Teradaira S., Sugimoto N., et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med 2007, 204:2803-2812.
11. Hosokawa Y., Nakanishi T., Yamaguchi D., Takahashi K., Yumoto H., Ozaki K., et al. Macrophage inflammatory protein 3alpha-CC chemokine receptor 6 interactions play an important role in CD4+ T-cell accumulation in periodontal diseased tissue. Clin Exp Immunol 2002, 128:548-554.
12. Hosokawa Y., Hosokawa I., Ozaki K., Nakae H., Matsuo T. Increase of CCL20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin. Clin Exp Immunol 2005, 142:285-291.
13. Hosokawa Y., Hosokawa I., Ozaki K., Nakanishi T., Nakae H., Matsuo T. Catechins inhibit CCL20 production in IL-17A-stimulated human gingival fibroblasts. Cell Physiol Biochem 2009, 24:391-396.
14. Kim Y.S., Min K.S., Jeong D.H., Jang J.H., Kim H.W., Kim E.C. Effects of fibroblast growth factor-2 on the expression and regulation of chemokines in human dental pulp cells. J Endod 2010, 36:1824-1830.
15. Ando T., Ichikawa J., Wako M., Hatsushika K., Watanabe Y., Sakuma M., et al. TWEAK/Fn14 interaction regulates RANTES production, BMP-2-induced differentiation, and RANKL expression in mouse osteoblastic MC3T3-E1 cells. Arthritis Res Ther 2006, 8:R146.
16. Vincent C., Findlay D.M., Welldon K.J., Wijenayaka A.R., Zheng T.S., Haynes D.R., et al. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. J Bone Miner Res 2009, 24:1434-1449.
17. Ghosh S.K., Gupta S., Jiang B., Weinberg A. Fusobacterium nucleatum and human beta defensins modulate the release of antimicrobial chemokine CCL20/Mip-3{alpha}. Infect Immun 2011, 79:4578-4587.
18. Kao C.Y., Huang F., Chen Y., Thai P., Wachi S., Kim C., et al. Up-regulation of CC chemokine ligand 20 expression in human airway epithelium by IL-17 through a JAK-independent but MEK/NF-kappaB-dependent signaling pathway. J Immunol 2005, 175:6676-6685.